Kristina Thamm1, Claudia Schrimpf2, Jennifer Retzlaff1, Temitayo O Idowu1, Matijs van Meurs3,4, Jan G Zijlstra3, Chandra C Ghosh5, Jana Zeitvogel6, Thomas A Werfel6, Hermann Haller1, Samir M Parikh3, Sascha David1. 1. Department of Nephrology and Hypertension, Hannover Medical School, Hannover, Germany. 2. Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany. 3. Medical Biology Section, Department of Pathology and Medical Biology, University Medical Centre Groningen, Groningen, The Netherlands. 4. Department of Critical Care, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. 5. Center for Vascular Biology Research and Division of Nephrology, Beth Israel Deaconess and Harvard Medical School, Boston, MA. 6. Division of Immunodermatology and Allergy Research, Department of Dermatology, Venerology and Allergy, Hannover Medical School, Hannover, Germany.
Abstract
OBJECTIVES: Tie2 is a tyrosine kinase receptor expressed by endothelial cells that maintains vascular barrier function. We recently reported that diverse critical illnesses acutely decrease Tie2 expression and that experimental Tie2 reduction suffices to recapitulate cardinal features of the septic vasculature. Here we investigated molecular mechanisms driving Tie2 suppression in settings of critical illness. DESIGN: Laboratory and animal research, postmortem kidney biopsies from acute kidney injury patients and serum from septic shock patients. SETTING: Research laboratories and ICU of Hannover Medical School, Harvard Medical School, and University of Groningen. PATIENTS: Deceased septic acute kidney injury patients (n = 16) and controls (n = 12) and septic shock patients (n = 57) and controls (n = 22). INTERVENTIONS: Molecular biology assays (Western blot, quantitative polymerase chain reaction) + in vitro models of flow and transendothelial electrical resistance experiments in human umbilical vein endothelial cells; murine cecal ligation and puncture and lipopolysaccharide administration. MEASUREMENTS AND MAIN RESULTS: We observed rapid reduction of both Tie2 messenger RNA and protein in mice following cecal ligation and puncture. In cultured endothelial cells exposed to tumor necrosis factor-α, suppression of Tie2 protein was more severe than Tie2 messenger RNA, suggesting distinct regulatory mechanisms. Evidence of protein-level regulation was found in tumor necrosis factor-α-treated endothelial cells, septic mice, and septic humans, all three of which displayed elevation of the soluble N-terminal fragment of Tie2. The matrix metalloprotease 14 was both necessary and sufficient for N-terminal Tie2 shedding. Since clinical settings of Tie2 suppression are often characterized by shock, we next investigated the effects of laminar flow on Tie2 expression. Compared with absence of flow, laminar flow induced both Tie2 messenger RNA and the expression of GATA binding protein 3. Conversely, septic lungs exhibited reduced GATA binding protein 3, and knockdown of GATA binding protein 3 in flow-exposed endothelial cells reduced Tie2 messenger RNA. Postmortem tissue from septic patients showed a trend toward reduced GATA binding protein 3 expression that was associated with Tie2 messenger RNA levels (p < 0.005). CONCLUSIONS: Tie2 suppression is a pivotal event in sepsis that may be regulated both by matrix metalloprotease 14-driven Tie2 protein cleavage and GATA binding protein 3-driven flow regulation of Tie2 transcript.
OBJECTIVES:Tie2 is a tyrosine kinase receptor expressed by endothelial cells that maintains vascular barrier function. We recently reported that diverse critical illnesses acutely decrease Tie2 expression and that experimental Tie2 reduction suffices to recapitulate cardinal features of the septic vasculature. Here we investigated molecular mechanisms driving Tie2 suppression in settings of critical illness. DESIGN: Laboratory and animal research, postmortem kidney biopsies from acute kidney injurypatients and serum from septic shockpatients. SETTING: Research laboratories and ICU of Hannover Medical School, Harvard Medical School, and University of Groningen. PATIENTS: Deceased septic acute kidney injurypatients (n = 16) and controls (n = 12) and septic shockpatients (n = 57) and controls (n = 22). INTERVENTIONS: Molecular biology assays (Western blot, quantitative polymerase chain reaction) + in vitro models of flow and transendothelial electrical resistance experiments in human umbilical vein endothelial cells; murine cecal ligation and puncture and lipopolysaccharide administration. MEASUREMENTS AND MAIN RESULTS: We observed rapid reduction of both Tie2 messenger RNA and protein in mice following cecal ligation and puncture. In cultured endothelial cells exposed to tumor necrosis factor-α, suppression of Tie2 protein was more severe than Tie2 messenger RNA, suggesting distinct regulatory mechanisms. Evidence of protein-level regulation was found in tumor necrosis factor-α-treated endothelial cells, septic mice, and septic humans, all three of which displayed elevation of the soluble N-terminal fragment of Tie2. The matrix metalloprotease 14 was both necessary and sufficient for N-terminal Tie2 shedding. Since clinical settings of Tie2 suppression are often characterized by shock, we next investigated the effects of laminar flow on Tie2 expression. Compared with absence of flow, laminar flow induced both Tie2 messenger RNA and the expression of GATA binding protein 3. Conversely, septic lungs exhibited reduced GATA binding protein 3, and knockdown of GATA binding protein 3 in flow-exposed endothelial cells reduced Tie2 messenger RNA. Postmortem tissue from septic patients showed a trend toward reduced GATA binding protein 3 expression that was associated with Tie2 messenger RNA levels (p < 0.005). CONCLUSIONS:Tie2 suppression is a pivotal event in sepsis that may be regulated both by matrix metalloprotease 14-driven Tie2 protein cleavage and GATA binding protein 3-driven flow regulation of Tie2 transcript.
Authors: Eirini Kefaloyianni; Muthu Lakshmi Muthu; Jakob Kaeppler; Xiaoming Sun; Venkata Sabbisetti; Athena Chalaris; Stefan Rose-John; Eitan Wong; Irit Sagi; Sushrut S Waikar; Helmut Rennke; Benjamin D Humphreys; Joseph V Bonventre; Andreas Herrlich Journal: JCI Insight Date: 2016-08-18
Authors: James E Dahlman; Carmen Barnes; Omar Khan; Aude Thiriot; Siddharth Jhunjunwala; Taylor E Shaw; Yiping Xing; Hendrik B Sager; Gaurav Sahay; Lauren Speciner; Andrew Bader; Roman L Bogorad; Hao Yin; Tim Racie; Yizhou Dong; Shan Jiang; Danielle Seedorf; Apeksha Dave; Kamaljeet S Sandu; Matthew J Webber; Tatiana Novobrantseva; Vera M Ruda; Abigail K R Lytton-Jean; Christopher G Levins; Brian Kalish; Dayna K Mudge; Mario Perez; Ludmila Abezgauz; Partha Dutta; Lynelle Smith; Klaus Charisse; Mark W Kieran; Kevin Fitzgerald; Matthias Nahrendorf; Dganit Danino; Rubin M Tuder; Ulrich H von Andrian; Akin Akinc; Avi Schroeder; Dipak Panigrahy; Victor Kotelianski; Robert Langer; Daniel G Anderson Journal: Nat Nanotechnol Date: 2014-05-11 Impact factor: 39.213
Authors: Matijs van Meurs; Neng F Kurniati; Francis M Wulfert; Sigridur A Asgeirsdottir; Inge A de Graaf; Simon C Satchell; Peter W Mathieson; Rianne M Jongman; Philipp Kümpers; Jan G Zijlstra; Peter Heeringa; Grietje Molema Journal: Am J Physiol Renal Physiol Date: 2009-06-10
Authors: Thomas Stiehl; Kristina Thamm; Jörg Kaufmann; Ute Schaeper; Torsten Kirsch; Hermann Haller; Ansgar Santel; Chandra C Ghosh; Samir M Parikh; Sascha David Journal: Crit Care Med Date: 2014-10 Impact factor: 7.598
Authors: Minah Kim; Breanna Allen; Emilia A Korhonen; Maximilian Nitschké; Hee Won Yang; Peter Baluk; Pipsa Saharinen; Kari Alitalo; Christopher Daly; Gavin Thurston; Donald M McDonald Journal: J Clin Invest Date: 2016-08-22 Impact factor: 14.808
Authors: Sabrina H van Ierssel; Philippe G Jorens; Emeline M Van Craenenbroeck; Viviane M Conraads Journal: Biomed Res Int Date: 2014-04-01 Impact factor: 3.411
Authors: Adnan Aslan; Rianne M Jongman; Jill Moser; Coen A Stegeman; Harry van Goor; Arjan Diepstra; Marius C van den Heuvel; Peter Heeringa; Grietje Molema; Jan G Zijlstra; Matijs van Meurs Journal: Crit Care Date: 2014-03-31 Impact factor: 9.097
Authors: Lan-Sun Chen; Sumeet P Singh; Gregor Müller; Stefan R Bornstein; Waldemar Kanczkowski Journal: Front Endocrinol (Lausanne) Date: 2020-01-22 Impact factor: 5.555